Permeation enhancers in transdermal drug delivery: benefits and limitations

References

• Pastore MN, Kalia YN, Horstmann M, et al. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172(9):2179–2209.
   PubMed Web of Science ®Google Scholar
• Guy RH. Transdermal drug delivery. In: Schäfer-Korting M, editor Drug Delivery. Handb Exp Pharmacol. vol 197, Berlin, Heidelberg: Springer, 2010;p. 399–410.
   PubMedGoogle Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–1268.
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115–124.
   PubMed Web of Science ®Google Scholar
• Williams A. Transdermal and topical drug delivery: from theory to clinical practice. London: Pharmaceutical Press; 2003.
   Google Scholar
• Asbill CS, El-Kattan AF, Michniak B. Enhancement of transdermal drug delivery: chemical and physical approaches. Crit Rev Ther Drug Carrier Syst. 2000;17(6):621–658.
   PubMed Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
   PubMed Web of Science ®Google Scholar
• Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23–33.
   PubMedGoogle Scholar
• Tiwary AK, Sapra B, Jain S. Innovations in transdermal drug delivery: formulations and techniques. Recent Pat Drug Deliv Formul. 2007;1(1):23–36.
   PubMedGoogle Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603–618.
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm. 1999;184(1):1–6.
   PubMed Web of Science ®Google Scholar
• Benson HA, Namjoshi S. Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci. 2008;97(9):3591–3610.
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! J Control Release. 2014;190:150–156.
   PubMed Web of Science ®Google Scholar
• Barry BW. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 1983.
   Google Scholar
• Kanikkannan N, Kandimalla K, Lamba SS, et al. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem. 2000;7(6):593–608.
   PubMed Web of Science ®Google Scholar
• Kaushik D, Batheja P, Kilfoyle B, et al. Percutaneous permeation modifiers: enhancement versus retardation. Expert Opin Drug Deliv. 2008;5(5):517–529.
   PubMed Web of Science ®Google Scholar
• Marjukka Suhonen T, Bouwstra JA, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. 1999;59(2):149–161.
   PubMed Web of Science ®Google Scholar
• Vavrova K, Zbytovska J, Hrabalek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem. 2005;12(19):2273–2291.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. Chemical penetration enhancers: A patent review. Expert Opin Ther Pat. 2009;19(7):969–988.
   PubMed Web of Science ®Google Scholar
• Aungst BJ. Absorption enhancers: applications and advances. Aaps J. 2012;14(1):10–18.
   PubMed Web of Science ®Google Scholar
• Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014;1841(3):280–294.
   PubMed Web of Science ®Google Scholar
• van Smeden J, Janssens M, Gooris GS, et al. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta. 2014;1841(3):295–313.
   PubMed Web of Science ®Google Scholar
• Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183–200.
   PubMed Web of Science ®Google Scholar
• Bouwstra J, Pilgram G, Gooris G, et al. New aspects of the skin barrier organization. Skin Pharmacol Appl Skin Physiol. 2001;14:52–62.
   PubMedGoogle Scholar
• Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 2006;1758(12):2080–2095.
   PubMed Web of Science ®Google Scholar
• Elias PM. Skin barrier function. Curr Allergy Asthma Rep. 2008;8(4):299–305.
   PubMed Web of Science ®Google Scholar
• Forslind B, Engstrom S, Engblom J, et al. A novel approach to the understanding of human skin barrier function. J Dermatol Sci. 1997;14(2):115–125.
   PubMed Web of Science ®Google Scholar
• Madison KC. Barrier function of the skin: “La raison d’etre” of the epidermis. J Invest Dermatol. 2003;121(2):231–241.
   PubMed Web of Science ®Google Scholar
• Menon GK, Kligman AM. Barrier functions of human skin: A holistic view. Skin Pharmacol Physiol. 2009;22(4):178–189.
   PubMed Web of Science ®Google Scholar
• Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072.
   PubMed Web of Science ®Google Scholar
• Wertz PW. Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh). 2000;208:7–11.
   PubMedGoogle Scholar
• Candi E, Schmidt R, Melino G. The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6(4):328–340.
   PubMed Web of Science ®Google Scholar
• Elias PM, Gruber R, Crumrine D, et al. Formation and functions of the corneocyte lipid envelope (cle). Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2014;1841(3):314–318.
   PubMed Web of Science ®Google Scholar
• Elias PM, Goerke J, Friend DS. Mammalian epidermal barrier layer lipids: composition and influence on structure. J Invest Dermatol. 1977;69(6):535–546.
   PubMed Web of Science ®Google Scholar
• Breiden B, Sandhoff K. The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim Biophys Acta. 2014;1841(3):441–452.
   PubMed Web of Science ®Google Scholar
• Rabionet M, Gorgas K, Sandhoff R. Ceramide synthesis in the epidermis. Biochim Biophys Acta. 2014;1841(3):422–434.
   PubMed Web of Science ®Google Scholar
• Vávrová K, Kováčik A, Opálka L. Ceramides in the skin barrier. Eur Pharm J. 2017;64(2):28–35.
   Google Scholar
• Bouwstra JA, Gooris GS, van der Spek JA, et al. Structural investigations of human stratum corneum by small-angle x-ray scattering. J Invest Dermatol. 1991;97(6):1005–1012.
   PubMed Web of Science ®Google Scholar
• Madison KC, Swartzendruber DC, Wertz PW, et al. Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol. 1987;88(6):714–718.
   PubMed Web of Science ®Google Scholar
• White SH, Mirejovsky D, King GI. Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum. An x-ray diffraction study. Biochemistry. 1988;27(10):3725–3732.
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Control Release. 2003;86(1):69–92.
   PubMed Web of Science ®Google Scholar
• Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9(5):663–669.
   PubMed Web of Science ®Google Scholar
• Scheuplein RJ. Mechanism of percutaneous absorption. Ii. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48(1):79–88.
   PubMed Web of Science ®Google Scholar
• Barry BW. Drug delivery routes in skin: A novel approach. Adv Drug Deliv Rev. 2002;54(Suppl 1):S31–40.
   PubMed Web of Science ®Google Scholar
• Schwenkenbecker A. Das absorptions verniogen der haut. Arch Anat Physiol. 1904;28:121–165.
   Google Scholar
• White RP. Poisoning from aniline black from shoes. Lancet. 1909;173(4457):349.
   Google Scholar
• Laws G. The effects of nitroglycerin upon those who manufacture it. J Am Med Assoc. 1898;31:793–794.
   Google Scholar
• Waters C. The development of the rotigotine transdermal patch a historical perspective. Neurol Clin. 2013;31(3):S37-+.
   PubMed Web of Science ®Google Scholar
• Stoughton RB. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Arch Dermatol. 1982;118(7):474–477.
   PubMedGoogle Scholar
• Rajadhyaksha VJ. Vehicle composition containing 1-substituted azacycloheptan-2-ones. 1976.
   Google Scholar
• Barry B. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release. 1991;15(3):237–248.
   Web of Science ®Google Scholar
• Smith EW, Maibach HI. Percutaneous penetration enhancers. Boca Raton: CRC Press; 1995.
   Google Scholar
• Dragicevic N, Maibach HI. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2016.
   Google Scholar
• Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85–97.
   Google Scholar
• Albery WJ, Hadgraft J. Percutaneous absorption: in vivo experiments. J Pharm Pharmacol. 1979;31(3):140–147.
   PubMed Web of Science ®Google Scholar
• Haq A, Chandler M, Michniak-Kohn B. Solubility-physicochemical-thermodynamic theory of penetration enhancer mechanism of action. Int J Pharm. 2019;575:118920.
   PubMedGoogle Scholar
• Janůšová B, Školová B, Tükörová K, et al. Amino acid derivatives as transdermal permeation enhancers. J Control Release. 2013;165(2):91–100.
   PubMed Web of Science ®Google Scholar
• Ongpipattanakul B, Burnette RR, Potts RO, et al. Evidence that oleic-acid exists in a separate phase within stratum-corneum lipids. Pharm Res. 1991;8(3):350–354.
   PubMed Web of Science ®Google Scholar
• Anigbogu ANC, Williams AC, Barry BW, et al. Fourier-transform raman-spectroscopy of interactions between the penetration enhancer dimethyl-sulfoxide and human stratum-corneum. Int J Pharm. 1995;125(2):265–282.
   Google Scholar
• Cornwell PA, Barry BW, Bouwstra JA, et al. Modes of action of terpene penetration enhancers in human skin differential scanning calorimetry, small-angle x-ray diffraction and enhancer uptake studies. Int J Pharm. 1996;127(1):9–26.
   Web of Science ®Google Scholar
• Yamane MA, Williams AC, Barry BW. Effects of terpenes and oleic-acid as skin penetration enhancers towards 5-fluorouracil as assessed with time - permeation, partitioning and differential scanning calorimetry. Int J Pharm. 1995;116(2):237–251.
   Google Scholar
• Eichner A, Stahlberg S, Sonnenberger S, et al. Influence of the penetration enhancer isopropyl myristate on stratum corneum lipid model membranes revealed by neutron diffraction and (2)h nmr experiments. Biochim Biophys Acta Biomembr. 2017;1859(5):745–755.
   PubMed Web of Science ®Google Scholar
• Pham QD, Bjorklund S, Engblom J, et al. Chemical penetration enhancers in stratum corneum - relation between molecular effects and barrier function. J Control Release. 2016;232:175–187.
   PubMed Web of Science ®Google Scholar
• Zulueta Díaz Y, Mottola M, Vico RV, et al. The rheological properties of lipid monolayers modulate the incorporation of l-ascorbic acid alkyl esters. Langmuir. 2016;32(2):587–595.
   PubMed Web of Science ®Google Scholar
• Curikova BA, Prochazkova K, Filkova B, et al. Simplified stratum corneum model membranes for studying the effects of permeation enhancers. Int J Pharm. 2017;534(1–2):287–296.
   PubMedGoogle Scholar
• Kopecna M, Kovacik A, Kucera O, et al. Fluorescent penetration enhancers reveal complex interactions among the enhancer, drug, solvent, and skin. Mol Pharm. 2019;16(2):886–897.
   PubMedGoogle Scholar
• Pandit J, Aqil M, Sultana Y Terpenes and essential oils as skin penetration enhancers. In: Dragicevic N, Maibach HI, editor. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 173–193.
   Google Scholar
• Babu RJ, Chen L, Kanikkannan N Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In: Dragicevic N, Maibach HI. (eds) Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 133–150.
   Google Scholar
• Bennett S, Barry B. Effectiveness of skin penetration enhancers propylene glycol, azone, decylmethylsulphoxide and oleic acid with model polar (mannitol) and nonpolar (hydrocortisone) penetrants. J Pharm Pharmacol. 1985;37(S12):84P–84P.
   PubMedGoogle Scholar
• Francoeur ML, Golden GM, Potts RO. Oleic-acid - its effects on stratum-corneum in relation to (trans)dermal drug delivery. Pharm Res. 1990;7(6):621–627.
   PubMed Web of Science ®Google Scholar
• Williams AC Urea and derivatives as penetration enhancers. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 301–308.
   Google Scholar
• Skolova B, Janusova B, Vavrova K. Ceramides with a pentadecasphingosine chain and short acyls have strong permeabilization effects on skin and model lipid membranes. Biochim Biophys Acta. 2016;1858(2):220–232.
   PubMed Web of Science ®Google Scholar
• Singh G, Karande P Peptide-mediated transdermal drug delivery. In: Dragicevic N, Maibach HI, editors, Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 353–361.
   Google Scholar
• Babu RJ, Chen L Pyrrolidones as penetration enhancers. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 291–299.
   Google Scholar
• Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol. 2004;22(2):192–197.
   PubMed Web of Science ®Google Scholar
• Kopečná M, Macháček M, Nováčková A, et al. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers. Sci Rep. 2019;9(1):14617.
   PubMedGoogle Scholar
• Kopečná M, Macháček M, Prchalová E, et al. Dodecyl amino glucoside enhances transdermal and topical drug delivery via reversible interaction with skin barrier lipids. Pharm Res. 2017;34(3):640–653.
   PubMed Web of Science ®Google Scholar
• Kopečná M, Macháček M, Prchalová E, et al. Galactosyl pentadecene reversibly enhances transdermal and topical drug delivery. Pharm Res. 2017;34(10):2097–2108.
   PubMed Web of Science ®Google Scholar
• Heard CM Ethanol and other alcohols: old enhancers, alternative perspectives. In: Dragicevic N, Maibach HI, editors, Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 151–172.
   Google Scholar
• MUNRO DD, Stoughton RB. Dimethylacetamide (dmac) and dimethylformamide (dmfa) effect on percutaneous absorption. Arch Dermatol. 1965;92(5):585–586.
   PubMedGoogle Scholar
• Javadzadeh Y, Adibkia K, Hamishekar H Transcutol®(diethylene glycol monoethyl ether): A potential penetration enhancer. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 195–205.
   Google Scholar
• Novotny J, Kovarikova P, Novotny M, et al. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination. Pharm Res. 2009;26(4):811–821.
   PubMed Web of Science ®Google Scholar
• Ghafourian T, Nokhodchi A, Kaialy W Surfactants as penetration enhancers for dermal and transdermal drug delivery. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; 2015. p. 207–230.
   Google Scholar
• Karande P, Jain A, Arora A, et al. Synergistic effects of chemical enhancers on skin permeability: A case study of sodium lauroylsarcosinate and sorbitan monolaurate. Eur J Pharm Sci. 2007;31(1):1–7.
   PubMed Web of Science ®Google Scholar
• Arellano A, Santoyo S, Martn C, et al. Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium. Eur J Drug Metab Pharmacokinet. 1998;23(2):307–312.
   PubMed Web of Science ®Google Scholar
• Cheng Y-L, Nedberge DE, Sugihara E. Skin permeation enhancer compositions using glycerol monolaurate. US 4,746,515. 1988.
   Google Scholar
• Menegatti S, Zakrewsky M, Kumar S, et al. De novo design of skin-penetrating peptides for enhanced transdermal delivery of peptide drugs. Adv Healthc Mater. 2016;5(5):602–609.
   PubMed Web of Science ®Google Scholar
• Hori M, Satoh S, Maibach HI, et al. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J Pharm Sci. 1991;80(1):32–35.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tamagawa S, Katagi T, et al. In vitro transport of sodium diclofenac across rat abdominal skin: effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem Pharm Bull (Tokyo). 1991;39(1):154–158.
   PubMed Web of Science ®Google Scholar
• Tanner EEL, Curreri AM, Balkaran JPR, et al. Design principles of ionic liquids for transdermal drug delivery. Adv Mater. 2019;31(27):e1901103.
   PubMed Web of Science ®Google Scholar
• Morganti F, Bramanti E, Solaro R, et al. Thermal and spectroscopic characterization of interactions between 2-nonyl-1,3-dioxolane and stratum corneum components. J Bioact Compat Polym. 1999;14(2):162–177.
   Web of Science ®Google Scholar
• Michniak B, Player M, Godwin D, et al. In vitro evaluation of a series of azone analogs as dermal penetration enhancers: iv. Amines. Int J Pharm. 1995;116(2):201–209.
   Google Scholar
• Michniak B, Player M, Fuhrman L, et al. In vitro evaluation of a series of azone analogs as dermal penetration enhancers: iii. Acyclic amides. Int J Pharm. 1994;110(3):231–239.
   Google Scholar
• Novotny J, Janusova B, Novotny M, et al. Short-chain ceramides decrease skin barrier properties. Skin Pharmacol Physiol. 2009;22(1):22–30.
   PubMed Web of Science ®Google Scholar
• Skolova B, Janusova B, Zbytovska J, et al. Ceramides in the skin lipid membranes: length matters. Langmuir. 2013;29(50):15624–15633.
   PubMed Web of Science ®Google Scholar
• Janusova B, Zbytovska J, Lorenc P, et al. Effect of ceramide acyl chain length on skin permeability and thermotropic phase behavior of model stratum corneum lipid membranes. Biochim Biophys Acta. 2011;1811(3):129–137.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Tojima H, Haruta T, et al. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J Pharm Pharmacol. 1996;48(11):1133–1137.
   PubMed Web of Science ®Google Scholar
• Golden GM, McKie JE, Potts RO. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci. 1987;76(1):25–28.
   PubMed Web of Science ®Google Scholar
• Chantasart D, Li SK, He N, et al. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci. 2004;93(3):762–779.
   PubMed Web of Science ®Google Scholar
• Warner KS, Li SK, He N, et al. Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action. J Pharm Sci. 2003;92(6):1305–1322.
   PubMed Web of Science ®Google Scholar
• Karande P, Jain A, Ergun K, et al. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102(13):4688–4693.
   PubMed Web of Science ®Google Scholar
• Hrabalek A, Dolezal P, Vavrova K, et al. Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin. Pharm Res. 2006;23(5):912–919.
   PubMed Web of Science ®Google Scholar
• Karande P, Mitragotri S. High throughput screening of transdermal formulations. Pharm Res. 2002;19(5):655–660.
   PubMed Web of Science ®Google Scholar
• Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009;1788(11):2362–2373.
   PubMed Web of Science ®Google Scholar
• Karande P, Jain A, Mitragotri S. Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release. 2006;115(1):85–93.
   PubMed Web of Science ®Google Scholar
• Tanner EEL, Ibsen KN, Mitragotri S. Transdermal insulin delivery using choline-based ionic liquids (cage). J Control Release. 2018;286:137–144.
   PubMed Web of Science ®Google Scholar
• Hirvonen J, Rytting JH, Paronen P, et al. Dodecyl n,n-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin. Pharm Res. 1991;8(7):933–937.
   PubMed Web of Science ®Google Scholar
• Buyuktimkin S, Buyuktimkin N, Rytting JH. Synthesis and enhancing effect of dodecyl 2-(n,n-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. Pharm Res. 1993;10(11):1632–1637.
   PubMed Web of Science ®Google Scholar
• Novotny M, Klimentova J, Janusova B, et al. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action. J Control Release. 2011;150(2):164–170.
   PubMed Web of Science ®Google Scholar
• Vavrova K, Hrabalek A, Dolezal P, et al. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers. J Control Release. 2005;104(1):41–49.
   PubMed Web of Science ®Google Scholar
• Montagna W. Histology and cytochemistry of human skin: ix. The distribution of non-specific esterases. J Cell Biol. 1955;1(1):13–16.
   Google Scholar
• Stinchcomb AL, Swaan PW, Ekabo O, et al. Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. J Pharm Sci. 2002;91(12):2571–2578.
   PubMed Web of Science ®Google Scholar
• Murphy M, Carmichael AJ. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol. 2000;1(6):361–368.
   PubMedGoogle Scholar
• Denda M, Kitamura K, Elias PM, et al. Trans-4-(aminomethyl)cyclohexane carboxylic acid (t-amcha), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol. 1997;109(1):84–90.
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Kumamoto J, Denda M. Tranexamic acid blocks the thrombin-mediated delay of epidermal permeability barrier recovery induced by the cedar pollen allergen, cry j1. Sci Rep. 2018;8(1):15610.
   PubMedGoogle Scholar
• Vavrova K, Lorencova K, Novotny J, et al. Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of ph, ion-pairing and skin species. Eur J Pharm Biopharm. 2008;70(3):901–907.
   PubMed Web of Science ®Google Scholar
• Schoellhammer CM, Blankschtein D, Langer R. Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expert Opin Drug Deliv. 2014;11(3):393–407.
   PubMed Web of Science ®Google Scholar